IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$10.03
-6.70% today
Updated 2026-04-29
Market cap
$135.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.20
Dividend yield
—
52W range
$5 – $15
Volume
2.8M
Immunic Inc (IMUX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $6000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | $1.33M | $206.00 | $998000.00 | $15000.00 | $50000.00 | $39000.00 | $85000.00 | $77000.00 | $111000.00 | $134000.00 | $168000.00 |
| Gross profit | — | — | — | — | $-1.33M | $5794.00 | $-998000.00 | $-15000.00 | $-50000.00 | $-39000.00 | $-85000.00 | $-77000.00 | $-111000.00 | $-134000.00 | $-168000.00 |
| Gross margin | — | — | — | — | — | 96.6% | — | — | — | — | — | — | — | — | — |
| R&D | $5.51M | $5.10M | $21.79M | $39.48M | $39.77M | $30.05M | $39.34M | $24.82M | $22.51M | $38.64M | $61.12M | $71.25M | $83.22M | $80.05M | $81.98M |
| SG&A | — | — | $9.62M | $10.86M | $12.35M | $11.22M | $13.31M | $13.59M | $14.52M | $10.33M | $13.30M | $15.26M | $16.01M | $18.01M | $21.25M |
| Operating income | $-8.58M | $-9.58M | $-31.40M | $-50.34M | $-52.12M | $-41.27M | $-52.66M | $-42.02M | $-37.03M | $-48.97M | $-91.67M | $-119.49M | $-99.22M | $-98.05M | $-103.23M |
| Operating margin | — | — | — | — | — | -687766.7% | — | — | — | — | — | — | — | — | — |
| EBITDA | $-7.62M | $-5.64M | $-31.92M | $-49.26M | $-50.79M | $-39.46M | $-51.08M | $-15.14M | $-36.98M | $-48.93M | $-91.58M | $-86.44M | $-99.11M | $-97.92M | $-97.00M |
| EBITDA margin | — | — | — | — | — | -657633.3% | — | — | — | — | — | — | — | — | — |
| EBIT | $-8.58M | $-6.29M | $-32.72M | $-50.34M | $-52.12M | $-41.27M | $-52.08M | $-15.15M | $-37.03M | $-48.97M | $-91.67M | $-86.52M | $-99.22M | $-98.05M | $-97.17M |
| Interest expense | $9.25M | $413000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $107000.00 | $58000.00 | $85000.00 | $1.04M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.88M | $-6.70M | $-32.72M | $-47.67M | $-52.02M | $-40.97M | $-52.08M | $-41.48M | $-34.83M | $-44.02M | $-92.79M | $-120.41M | $-93.61M | $-100.51M | $-97.17M |
| Net income growth (YoY) | — | -14.0% | -388.3% | -45.7% | -9.1% | +21.2% | -27.1% | +20.4% | +16.0% | -26.4% | -110.8% | -29.8% | +22.3% | -7.4% | +3.3% |
| Profit margin | — | — | — | — | — | -682816.7% | — | — | — | — | — | — | — | — | — |